Fig. 1From: Lower starting dose of afatinib for the treatment of metastatic lung adenocarcinoma harboring exon 21 and exon 19 mutationsPFS and OS for afatinib treatment. a PFS in patients receiving different initial doses of afatinib. b OS for patients receiving different initial doses of afatinibBack to article page